EQS Group-Media / 2020-02-28 / 19:30
*Media Release*
*Medacta Spotlights Knee Sports Medicine and Knee Arthroplasty at* *the 2nd
M.O.R.E. Australian Knee Symposium*
_CASTEL SAN PIETRO_, _28 February 2020_ - Medacta today announces its 2nd
M.O.R.E. Australian Knee Symposium, which will be held on February 29 to
March 1, 2020 in Gold Coast, QLD (Australia).
The Symposium will welcome over 80 surgeons from Australia and overseas who
will gather to discuss controversies and complexities surrounding topics
related to knee sports medicine and knee arthroplasty.
Following the success of the 1st M.O.R.E. Australian Knee Symposium 2018,
this 2nd Symposium includes content on sports medicine, a growing business
unit for Medacta, especially considering its recent approvals for multiple
sports medicine products. The 2nd M.O.R.E. Australian Symposium features two
main didactic programs, Sports Medicine and Knee Arthroplasty. Each of these
will contain sessions and unique case studies, as well as an instructional
course lecture aimed at senior registrars and fellows, chaired by
professional surgeons.
Reflecting Medacta's ongoing commitment to continuous medical education, the
symposium will include a total of eight sessions, which will take place over
the course of the two-day meeting.
The Sports Medicine sessions will address topics such as ligament injuries,
ACL reconstruction and complex soft tissue surgery, whereas the arthroplasty
sessions will include content on auxiliary measures to improve outcomes,
medially stabilized implants, optimizing patient specific kinematics,
technology and tools, as well as revision and complex TKA.
The Symposium will be chaired by Dr. Myles Coolican, along with Dr. Stephen
Howell from the Adventist Health Lodi Memorial (Lodi, California) and Dr.
Robert Smigielski from the Medical University of Warsaw (Warsaw, Poland) as
international guests.
The 2nd M.O.R.E. Australian Knee Symposium is organized by the M.O.R.E.
Institute, which gives hands-on support for surgeons transitioning to new
techniques. "Medacta relies on education to transform innovation into
concrete benefits for patients, surgeons and healthcare systems", states
Francesco Siccardi, CEO of Medacta. "The surgeon is at the center of
Medacta's ecosystem and we are committed to providing our surgeons with
continuous support to more efficiently and effectively meet their patients'
needs."
For more information about the M.O.R.E. Institute, visit more.medacta.com.
*Contact*
Medacta International SA
Gianluca Olgiati
Senior Director Global Marketing
Phone: +41 91 696 60 60
media@medacta.ch
*About Medacta*
Medacta is an international company specializing in the design and
production of innovative orthopaedic products and the development of
accompanying surgical techniques for joint replacement, spine surgery, and
sports medicine. Established in 1999 in Switzerland, Medacta's products and
surgical techniques are characterized by innovation. Medacta is a pioneer in
developing new offerings on the basis of minimally invasive surgical
techniques, in particular its Anterior Minimally Invasive Surgery ("AMIS")
technique for hip replacements. Medacta has leveraged its orthopaedic
expertise and comprehensive understanding of the human body to develop the
sophisticated "MySolutions" technology, which offers surgeons highly
personalized pre-operative planning and implant placement methodologies by
creating advanced personalized kinematic models and 3D planning tools for
use in hip, knee, shoulder and spine procedures.
Issuer: Medacta Group SA
Key word(s): Health
End of Corporate News
Language: English
Company: Medacta Group SA
Strada Regina
6874 Castel San Pietro
Switzerland
Phone: +41 91 696 6060
E-mail: info@medacta.ch, investor.relations@medacta.ch
Internet: www.medacta.com
ISIN: CH0468525222
Listed: SIX Swiss Exchange
EQS News ID: 986793
End of News EQS Group Media
986793 2020-02-28
(END) Dow Jones Newswires
February 28, 2020 13:30 ET (18:30 GMT)
© 2020 Dow Jones News
